<DOC>
	<DOCNO>NCT00195559</DOCNO>
	<brief_summary>The purpose study determine whether Levonorgestrel/Ethinyl Estradiol ( LNG/EE ) effective treating symptom severe Premenstrual Dysphoric Disorder .</brief_summary>
	<brief_title>Study Evaluating Combination Levonorgestrel Ethinyl Estradiol Pre-Menstrual Dysphoric Disorder</brief_title>
	<detailed_description />
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Premenstrual Dysphoric Disorder</mesh_term>
	<mesh_term>Menstruation Disturbances</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Generally healthy , woman age 18 49 year . History severe PMS symptom last year , determine investigator . Regular 21 35 day menstrual cycle 2 month prior first study visit . Major depressive disorder require antidepressant treatment hospitalization within last 3 year . Contraindication combination oral contraceptive . Use antidepressants/anxiolytics within 10 day screen duration study . Other exclusion applies .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Premenstrual Syndrome ( PMS )</keyword>
	<keyword>Hormone Therapy</keyword>
</DOC>